Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Asset Utilization Ratio: 2025

Historic Asset Utilization Ratio for Silence Therapeutics (SLN) over the last 2 years, with Sep 2025 value amounting to 0.04.

  • Silence Therapeutics' Asset Utilization Ratio was N/A to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year change of. This contributed to the annual value of 0.27 for FY2024, which is N/A change from last year.
  • Silence Therapeutics' Asset Utilization Ratio amounted to 0.04 in Q3 2025, which was down 28.60% from 0.06 recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' Asset Utilization Ratio ranged from a high of 0.29 in Q2 2024 and a low of 0.04 during Q3 2025.